Related Experiment Video
Updated: Aug 8, 2026

Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice
Published on: January 20, 2015
Pharmacology down under in 2000
1Doggrell Biomedical Communications, Lynfield, Auckland, New Zealand.
Abstract:
In December the pharmacologists and toxicologists of Australia and New Zealand get together for their annual scientific meeting, which is made up of pre-meeting workshops followed by invited lectures, symposia and free communications. This year, one of the pre-meeting workshops was on "Animal Models for the Development of Molecular Pharmaceuticals." Symposia included "Models and New Therapies for Traumatic Brain Injury" and "New Targets for Rheumatoid Arthritis." Novel medicines being developed in Australia revealed at the meeting included potassium channel blockers, C5a receptor agonists and antagonists, brain-derived neurotrophic factor mimetics and AM-36.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacogenomics: Identification of New Drug Targets

